Sign In
Buy CRY
$17.66
-0.374 (-2.07%)
At Close: Jul 17, 2026
Baxter Announces Acquisition of PerClot Polysaccharide Hemostatic System to Expand Advanced Surgery Portfolio
08:00am, Thursday, 29'th Jul 2021
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced its Baxter Healthcare Corporation subsidiary has completed the acquisition
CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results
04:25pm, Thursday, 15'th Jul 2021
ATLANTA, July 15, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2021 financial results
CryoLife to Participate in the UBS Global Healthcare Virtual Conference
08:35am, Tuesday, 18'th May 2021
ATLANTA, May 18, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming UB
CryoLife, Inc.: Regulatory Tailwinds For FY2021, 23% Upside Potential
03:40pm, Wednesday, 12'th May 2021
CryoLife continues to perform on recent fundamental and technical momentum, where shareholders have enjoyed +25% upside YTD.
CryoLife (CRY) Soars 24.2%: Is Further Upside Left in the Stock?
09:01am, Monday, 03'rd May 2021
CryoLife (CRY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the roa
CryoLife, Inc. (CRY) CEO Pat Mackin on Q1 2021 Results - Earnings Call Transcript
08:04pm, Friday, 30'th Apr 2021
CryoLife, Inc. (CRY) CEO Pat Mackin on Q1 2021 Results - Earnings Call Transcript
CRY Stock: From $23.49 To Over $27 Explanation
11:47am, Friday, 30'th Apr 2021
The stock price of Cryolife Inc (NYSE: CRY) increased from $23.49 to over $27 during intraday trading this morning. This is why it happened.
CryoLife Announces Release Date and Teleconference Call Details for First Quarter 2021 Financial Results
08:35am, Thursday, 15'th Apr 2021
ATLANTA, April 15, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2021 financial result
CryoLife to Participate in 20th Annual Needham Virtual Healthcare Conference
08:35am, Wednesday, 07'th Apr 2021
ATLANTA, April 7, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 20
CryoLife's (CRY) CEO Pat Mackin on Q4 2020 Results - Earnings Call Transcript
07:56pm, Thursday, 11'th Feb 2021
CryoLife's (CRY) CEO Pat Mackin on Q4 2020 Results - Earnings Call Transcript
CryoLife (CRY) Beats Q4 Earnings and Revenue Estimates
07:40pm, Thursday, 11'th Feb 2021
CryoLife (CRY) delivered earnings and revenue surprises of 1100.00% and 4.46%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Recap: Cryolife Q4 Earnings
05:08pm, Thursday, 11'th Feb 2021
Shares of Cryolife (NYSE:CRY) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 81.82% over the past year to $0.20, which beat the esti
CryoLife: Upside Potential Via Operating Leverage But Liquidity Pressures Loom
03:51pm, Wednesday, 16'th Dec 2020
CryoLife has a resilient portfolio mix that is bolstered by upcoming regulatory catalysts. The company has decent upside potential through operations, however, this may already be reflected in valuati
CryoLife to Host Webcast Discussing PROACT Xa Clinical Trial on December 7, 2020
08:30am, Thursday, 19'th Nov 2020
ATLANTA, Nov. 19, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will host a webcast for investors a
CryoLife's (CRY) CEO Pat Mackin on Q3 2020 Results - Earnings Call Transcript
10:39pm, Wednesday, 04'th Nov 2020
CryoLife's (CRY) CEO Pat Mackin on Q3 2020 Results - Earnings Call Transcript
